Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.

Prichard MN, Kaiwar R, Jackman WT, Quenelle DC, Collins DJ, Kern ER, Kemble GM, Spaete RR.

Vaccine. 2005 Nov 16;23(46-47):5424-31. Epub 2005 Mar 19.

PMID:
15950327
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

BenMohamed L, Bertrand G, McNamara CD, Gras-Masse H, Hammer J, Wechsler SL, Nesburn AB.

J Virol. 2003 Sep;77(17):9463-73.

PMID:
12915561
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Papillomavirus vaccines in clinical trials.

Galloway DA.

Lancet Infect Dis. 2003 Aug;3(8):469-75. Review.

PMID:
12901889
[PubMed - indexed for MEDLINE]
4.

Viral inhibition of MHC class II antigen presentation.

Hegde NR, Chevalier MS, Johnson DC.

Trends Immunol. 2003 May;24(5):278-85. Review. No abstract available.

PMID:
12738423
[PubMed - indexed for MEDLINE]
5.

Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.

Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR.

J Infect Dis. 2003 Feb 15;187(4):542-9. Epub 2003 Feb 7.

PMID:
12599070
[PubMed - indexed for MEDLINE]
Free Article
6.

Oncolytic herpes simplex virus vectors for cancer virotherapy.

Varghese S, Rabkin SD.

Cancer Gene Ther. 2002 Dec;9(12):967-78. Review.

PMID:
12522436
[PubMed - indexed for MEDLINE]
Free Article
7.

Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.

Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L.

JAMA. 2003 Jan 8;289(2):203-9.

PMID:
12517231
[PubMed - indexed for MEDLINE]
8.

Glycoprotein-D-adjuvant vaccine to prevent genital herpes.

Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, Tyring S, Aoki FY, Slaoui M, Denis M, Vandepapeliere P, Dubin G; GlaxoSmithKline Herpes Vaccine Efficacy Study Group.

N Engl J Med. 2002 Nov 21;347(21):1652-61.

PMID:
12444179
[PubMed - indexed for MEDLINE]
Free Article
9.

A controlled trial of a human papillomavirus type 16 vaccine.

Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; Proof of Principle Study Investigators.

N Engl J Med. 2002 Nov 21;347(21):1645-51.

PMID:
12444178
[PubMed - indexed for MEDLINE]
Free Article
10.

Counteraction of interferon-induced antiviral responses by herpes simplex viruses.

Leib DA.

Curr Top Microbiol Immunol. 2002;269:171-85. Review.

PMID:
12224508
[PubMed - indexed for MEDLINE]
11.

Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.

Gierynska M, Kumaraguru U, Eo SK, Lee S, Krieg A, Rouse BT.

J Virol. 2002 Jul;76(13):6568-76.

PMID:
12050369
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.

Gyotoku T, Ono F, Aurelian L.

Vaccine. 2002 Jun 21;20(21-22):2796-807.

PMID:
12034107
[PubMed - indexed for MEDLINE]
13.

Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994.

Xu F, Schillinger JA, Sternberg MR, Johnson RE, Lee FK, Nahmias AJ, Markowitz LE.

J Infect Dis. 2002 Apr 15;185(8):1019-24. Epub 2002 Mar 22.

PMID:
11930310
[PubMed - indexed for MEDLINE]
Free Article
14.

Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer.

Rees RC, McArdle S, Mian S, Li G, Ahmad M, Parkinson R, Ali SA.

Curr Opin Mol Ther. 2002 Feb;4(1):49-53. Review.

PMID:
11883695
[PubMed - indexed for MEDLINE]
15.

Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population.

Ribes JA, Steele AD, Seabolt JP, Baker DJ.

J Clin Microbiol. 2001 Sep;39(9):3321-5.

PMID:
11526170
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Soong SJ, Kiell J, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Pediatrics. 2001 Aug;108(2):223-9.

PMID:
11483781
[PubMed - indexed for MEDLINE]
17.

Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells.

Barcy S, Corey L.

J Immunol. 2001 May 15;166(10):6242-9.

PMID:
11342647
[PubMed - indexed for MEDLINE]
Free Article
18.

A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals.

Mohr I, Sternberg D, Ward S, Leib D, Mulvey M, Gluzman Y.

J Virol. 2001 Jun;75(11):5189-96.

PMID:
11333900
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Incidence of herpes simplex virus type 2 infection in the United States.

Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM, St Louis ME.

Am J Epidemiol. 2001 May 1;153(9):912-20.

PMID:
11323323
[PubMed - indexed for MEDLINE]
Free Article
20.

Viral immune evasion strategies and the underlying cell biology.

Lorenzo ME, Ploegh HL, Tirabassi RS.

Semin Immunol. 2001 Feb;13(1):1-9. Review.

PMID:
11289794
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk